ARTICLE | Financial News
TCR2 raises $44.5M in series A round
December 8, 2016 12:51 AM UTC
Immuno-oncology company TCR2 Therapeutics Inc. (Cambridge, Mass.) raised $44.5 million in a series A round led by MPM Capital and F2 Ventures...
Immuno-oncology company TCR2 Therapeutics Inc. (Cambridge, Mass.) raised $44.5 million in a series A round led by MPM Capital and F2 Ventures...